What is Profusa, Inc. Common Stock's market cap?

Profusa, Inc. Common Stock (PFSA) has a market capitalization of $646.6K and trades on NASDAQ.

Who are Profusa, Inc. Common Stock's competitors?

Profusa, Inc. Common Stock's key competitors include Abbott, Medtronic, Senseonics, and others. These companies compete in similar markets and product categories.

Who does Profusa, Inc. Common Stock partner with?

Profusa, Inc. Common Stock's notable partners include DARPA, National Institutes of Health, 3E Bioventures, and others.

Where is Profusa, Inc. Common Stock headquartered?

Profusa, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.

Profusa, Inc. Common Stock

PFSA

Profusa is a digital health technology company that develops a unique biosensor platform designed for real-time, long-term biochemistry monitoring.

Market cap

$646.6K-97.3%

Table of contents

Earnings

Q1 2026 report

May 15, 2026

EPS-$2.05

Read the full report

Next report

Date not yet announced

Competitors

By market cap

Abbott$182.00B-17.2%

Medtronic$107.81B-8.5%

DexCom$28.3B-19.4%

Philips$24.3B+2.4%

MiMedx Group$634.5M-36.7%

Senseonics Holdings, Inc. $261.5M-40.2%

Corvex $22.0M+325%

Profusa, Inc. Common Stock$646.6K-99.0%

By revenue growth

Corvex +89.0%

Senseonics Holdings, Inc. +71.9%

By net margin

DexCom19.31%+6.4pp

Medtronic13.2%-0.7pp

Abbott11.65%-20.8pp

MiMedx Group1.76%-7.1pp

Senseonics Holdings, Inc. -214.13%+98.3pp

Corvex -2,457.53%+3,487pp

Profile

Profusa is a digital health technology company that develops a unique biosensor platform designed for real-time, long-term biochemistry monitoring. The company's core value proposition is its tissue-integrated hydrogel sensors that function for up to nine months without triggering the body's foreign body response, bridging the gap between clinical-grade diagnostics and consumer wearables.

Competitive position

Profusa differentiates itself through its proprietary hydrogel technology that avoids the 'foreign body response,' allowing for significantly longer sensor life than current market leaders.

GeographiesUnited States, European Union, Asia Pacific

Customer segmentsHealthcare Providers, Chronic Disease Patients, Enterprise Technology Partners

Business modelB2B, Hardware-as-a-Service, Data-driven services

SuppliersHydrogel material suppliers, Contract manufacturers, Sterilization service providers, Electronic component manufacturers

CustomersMedical distributors, Hospitals, Telemedicine platforms, Chronic disease patients

CountryUnited States of America

Listed2025

CEOBen Chung-Bin Hwang

SectorHealthcare

IndustryMedical - Devices

Websiteprofusa.com

FilingsSEC EDGAR

Questions, answered.

What is Profusa, Inc. Common Stock's market cap?: Profusa, Inc. Common Stock (PFSA) has a market capitalization of $646.6K and trades on NASDAQ.
Who are Profusa, Inc. Common Stock's competitors?: Profusa, Inc. Common Stock's key competitors include Abbott, Medtronic, Senseonics, and others. These companies compete in similar markets and product categories.
Who does Profusa, Inc. Common Stock partner with?: Profusa, Inc. Common Stock's notable partners include DARPA, National Institutes of Health, 3E Bioventures, and others.
Where is Profusa, Inc. Common Stock headquartered?: Profusa, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.